FDA DEVICE FACTS
SOMNUM (SOMNUM)
Honeynaps Co., Ltd.
FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。
Indications for use
SOMNUM is an AI-enabled software program intended for use as an aid in the diagnosis of sleep and respiratory-related sleep disorders. SOMNUM is intended to be used for analysis — including automatic scoring using AI/ML algorithms for sleep stage classification, arousal detection, respiratory event detection, and leg movement event detection, as well as manual scoring/re-scoring, display, redisplay (retrieve), summarization, and report generation of digital data collected by monitoring devices typically used to evaluate sleep and respiratory-related sleep disorders. The device is to be used under the supervision of a physician. Use is restricted to data obtained from adult patients. Prescription Use. Age group: Adults (22 years old and greater).
Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。
OFFICIAL FDA SOURCES
FDA Record and Public Document Status
Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。